Skip to Content

LOGO 2120 (Valproic Acid 250 mg)

Pill with imprint LOGO 2120 is White, Capsule-shape and has been identified as Valproic Acid 250 mg. It is supplied by United Research Laboratories/Mutual Pharmaceutical Company.

Valproic acid is used in the treatment of epilepsy; seizure prevention; schizoaffective disorder; mania; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Valproic acid 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LOGO 2120

Valproic acid 250 mg LOGO 2120

Valproic Acid

LOGO 2120
250 mg
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
United Research Laboratories/Mutual Pharmaceutical Company
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.